PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective st...
Leadership
David H. Mack Ph.D.Founder
Co-Founder, CEO, President & Director
Arnold J. Levine Ph.D.Founder
Co-Founder, Independent Director & Member of Scientific Advisory Board
Robert Ticktin J.D.
General Counsel, COO & Company Secretary
Deepika Jalota Pharm.D.
Chief Development Officer
Michael Carulli
Chief Financial Officer
Tim Smith M.B.A.
Senior VP and Head of Corporate Development & Investor Relations
Crystal Zuckerman
Vice President of Human Resources
Binh Vu Ph.D.
Senior Vice President of Drug Discovery & CMC
Marc Fellous M.D.
Senior VP and Head of Clinical Development & Medical Affairs
